Skip to content

A clinical study to study the drug kadukkai chooranam on Neerizhivu

A prospective open labelled phase II non randomized clinical trial on herbal formulation of "Kadukkai Chooranam" for the treatment of Akkini selathumam (Diabetic Neuropathy)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012756
Enrollment
40
Registered
2018-03-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Akkini Selathumam

Interventions

Intervention1: Kadukkai Chooranam: 25 mg/kg/BW daily two times with warm water 90 days Control Intervention1: Not applicabli: Not applicable Control Intervention2: Not applicable: Not applicable

Sponsors

Dr S Neelavathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Type II diabetes mellitus Previously diagnosed patients which are uncontrolled or poorly controlled for more than 5 years duration of the illness If yes in any of three FBS above 126 mg per dl and below and equal 250mg per dl or PPBS above 200 mg per dl and below and equal 350mg per dl HbA1c above 6.5 and below 12 Patients with diabetic neuritis complains such as pain numbness tingling sensation of the lower limb Neuropathic pain scale is less than 4 by 10 The clinical diagnosis was confirmed by of nerve condution studies

Exclusion criteria

Exclusion criteria: B12 deficiency Severe anaemia Smoking or alcohol neuropathy Presence of foot ulcer Endocrine disorder Myopathy Systemic hypertension Angina and heart failure Type I diabetes mellitus Pregnancy Lactating mother Chronic kidney disease or renal failure Chronic liver disease Femoral nerve dysfunction Mechanical and traumatic nerve injury

Design outcomes

Primary

MeasureTime frame
The therapeutic efficacy of trial drug kadukkai chooranam on AKKINI SELATHUMAMTimepoint: The therapeutic efficacy of trial drug kadukkai chooranam on AKKINI SELATHUMAM

Secondary

MeasureTime frame
Evaluation of Siddha diagnostic parametersTimepoint: 90 days

Countries

India

Contacts

Public ContactDr A Manoharan MD Siddha

Government Siddha Medical college and hospital

drmanoharan25@gmail.com9443886700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026